Cargando…
Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms
Mutations in SF3B1 are found in 20% of myelodysplastic syndromes and 5–10% of myeloproliferative neoplasms, where they are considered important for diagnosis and therapy decisions. Sanger sequencing and NGS are the currently available methods to identify SF3B1 mutations, but both are time-consuming...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911290/ https://www.ncbi.nlm.nih.gov/pubmed/35268357 http://dx.doi.org/10.3390/jcm11051267 |
_version_ | 1784666759786135552 |
---|---|
author | Petiti, Jessica Itri, Federico Signorino, Elisabetta Frolli, Antonio Fava, Carmen Armenio, Marco Marini, Silvia Giugliano, Emilia Lo Iacono, Marco Saglio, Giuseppe Cilloni, Daniela |
author_facet | Petiti, Jessica Itri, Federico Signorino, Elisabetta Frolli, Antonio Fava, Carmen Armenio, Marco Marini, Silvia Giugliano, Emilia Lo Iacono, Marco Saglio, Giuseppe Cilloni, Daniela |
author_sort | Petiti, Jessica |
collection | PubMed |
description | Mutations in SF3B1 are found in 20% of myelodysplastic syndromes and 5–10% of myeloproliferative neoplasms, where they are considered important for diagnosis and therapy decisions. Sanger sequencing and NGS are the currently available methods to identify SF3B1 mutations, but both are time-consuming and expensive techniques that are not practicable in most small-/medium-sized laboratories. To identify the most frequent SF3B1 mutation, p.Lys700Glu, we developed a novel fast and cheap assay based on PNA-PCR clamping. After setting the optimal PCR conditions, the limit of detection of PNA-PCR clamping was evaluated, and the method allowed up to 0.1% of mutated SF3B1 to be identified. Successively, PNA-PCR clamping and Sanger sequencing were used to blind test 90 DNA from patients affected by myelodysplastic syndromes and myeloproliferative neoplasms for the SF3B1 p.Lys700Glu mutation. PNA-PCR clamping and Sanger sequencing congruently identified 75 negative and 13 positive patients. Two patients identified as positive by PNA-PCR clamping were missed by Sanger analysis. The discordant samples were analyzed by NGS, which confirmed the PNA-PCR clamping result, indicating that these samples contained the SF3B1 p.Lys700Glu mutation. This approach could easily increase the characterization of myelodysplastic syndromes and myeloproliferative neoplasms in small-/medium-sized laboratories, and guide patients towards more appropriate therapy. |
format | Online Article Text |
id | pubmed-8911290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89112902022-03-11 Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms Petiti, Jessica Itri, Federico Signorino, Elisabetta Frolli, Antonio Fava, Carmen Armenio, Marco Marini, Silvia Giugliano, Emilia Lo Iacono, Marco Saglio, Giuseppe Cilloni, Daniela J Clin Med Article Mutations in SF3B1 are found in 20% of myelodysplastic syndromes and 5–10% of myeloproliferative neoplasms, where they are considered important for diagnosis and therapy decisions. Sanger sequencing and NGS are the currently available methods to identify SF3B1 mutations, but both are time-consuming and expensive techniques that are not practicable in most small-/medium-sized laboratories. To identify the most frequent SF3B1 mutation, p.Lys700Glu, we developed a novel fast and cheap assay based on PNA-PCR clamping. After setting the optimal PCR conditions, the limit of detection of PNA-PCR clamping was evaluated, and the method allowed up to 0.1% of mutated SF3B1 to be identified. Successively, PNA-PCR clamping and Sanger sequencing were used to blind test 90 DNA from patients affected by myelodysplastic syndromes and myeloproliferative neoplasms for the SF3B1 p.Lys700Glu mutation. PNA-PCR clamping and Sanger sequencing congruently identified 75 negative and 13 positive patients. Two patients identified as positive by PNA-PCR clamping were missed by Sanger analysis. The discordant samples were analyzed by NGS, which confirmed the PNA-PCR clamping result, indicating that these samples contained the SF3B1 p.Lys700Glu mutation. This approach could easily increase the characterization of myelodysplastic syndromes and myeloproliferative neoplasms in small-/medium-sized laboratories, and guide patients towards more appropriate therapy. MDPI 2022-02-25 /pmc/articles/PMC8911290/ /pubmed/35268357 http://dx.doi.org/10.3390/jcm11051267 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Petiti, Jessica Itri, Federico Signorino, Elisabetta Frolli, Antonio Fava, Carmen Armenio, Marco Marini, Silvia Giugliano, Emilia Lo Iacono, Marco Saglio, Giuseppe Cilloni, Daniela Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms |
title | Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms |
title_full | Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms |
title_fullStr | Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms |
title_full_unstemmed | Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms |
title_short | Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms |
title_sort | detection of sf3b1 p.lys700glu mutation by pna-pcr clamping in myelodysplastic syndromes and myeloproliferative neoplasms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911290/ https://www.ncbi.nlm.nih.gov/pubmed/35268357 http://dx.doi.org/10.3390/jcm11051267 |
work_keys_str_mv | AT petitijessica detectionofsf3b1plys700glumutationbypnapcrclampinginmyelodysplasticsyndromesandmyeloproliferativeneoplasms AT itrifederico detectionofsf3b1plys700glumutationbypnapcrclampinginmyelodysplasticsyndromesandmyeloproliferativeneoplasms AT signorinoelisabetta detectionofsf3b1plys700glumutationbypnapcrclampinginmyelodysplasticsyndromesandmyeloproliferativeneoplasms AT frolliantonio detectionofsf3b1plys700glumutationbypnapcrclampinginmyelodysplasticsyndromesandmyeloproliferativeneoplasms AT favacarmen detectionofsf3b1plys700glumutationbypnapcrclampinginmyelodysplasticsyndromesandmyeloproliferativeneoplasms AT armeniomarco detectionofsf3b1plys700glumutationbypnapcrclampinginmyelodysplasticsyndromesandmyeloproliferativeneoplasms AT marinisilvia detectionofsf3b1plys700glumutationbypnapcrclampinginmyelodysplasticsyndromesandmyeloproliferativeneoplasms AT giuglianoemilia detectionofsf3b1plys700glumutationbypnapcrclampinginmyelodysplasticsyndromesandmyeloproliferativeneoplasms AT loiaconomarco detectionofsf3b1plys700glumutationbypnapcrclampinginmyelodysplasticsyndromesandmyeloproliferativeneoplasms AT sagliogiuseppe detectionofsf3b1plys700glumutationbypnapcrclampinginmyelodysplasticsyndromesandmyeloproliferativeneoplasms AT cillonidaniela detectionofsf3b1plys700glumutationbypnapcrclampinginmyelodysplasticsyndromesandmyeloproliferativeneoplasms |